Discussion
Although complete resolution and recovery occurs in most children with an initial attack of AP, a subset of children might progress to RAP.11 12 In this study, we identified a total of 30 (31.3%) children that progressed from AP to RAP, which is consistent with previously published recurrence rates of 10%–35% in the pediatric population13 14 and of 10%–32% in adults.15 16 We also found that the majority of the children (27/30, 90%) that developed RAP had progressed within 6 months after first episode of AP. This finding suggests that close follow-up within 6 months after discharge is very necessary and should be emphasized when giving parental counseling and anticipatory guidance of children.
In this study, RAP was more common in children who met all three AP diagnostic criteria at initial attack and with SIRS, long fasting time and abnormal amylase/lipase (above the upper limit of normal) value on the seventh day of hospitalization. Previous literatures reported that local pancreatic or systemic complications at initial attack and severity of first-time AP were associated with pediatric RAP.7 17 18 However, no literature has been reported about these three factors as independent risk factors of RAP in children.
It has been reported that RAP is closely related to the etiology of the first episode of AP19 and that pancreaticobiliary maljunction (PBM) was one of the major causes of RAP in adults.16 However, we did not observe this conclusion in the present study of our pediatric population. First, only children with abnormal ultrasound/ CT finding may receive MRI examination (n=26) in this center, which may result in the omission of biliopancreatic disease. In addition, some children received radical surgical treatment during hospitalization (n=4) or within a short time after discharge (n=9), which might cover up RAP and bias the results. Through follow-up, we found that these children had a good prognosis without RAP. Therefore, etiological surgical treatment for AP can effectively prevent RAP.
Children with AP were confirmed by meeting at least two of three INSPPIRE criteria.8 However, there are many pediatric AP patients that meet only two diagnostic criteria. We found that these children had a faster recovery and a better prognosis given the mild condition. At present, the treatment of pediatric AP is controversial. Early enteral nutrition is thought to be beneficial20 21 but is rarely performed.22 It is accepted that no antibiotic treatment should be given unless there is clear evidence of infection.23 In addition, the efficacy of protease inhibitors24 25 and somatostatin 26 27 is uncertain. Therefore, grouping children in this way can be considered in future research to explore more favorable treatment methods. Incomplete AP may not require complex management that necessitates longer hospitalization.
SIRS status can be used to identify children at risk for the development of SAP.28 Serum amylase and lipase are the most widely used enzymes for assessment of AP. In our cohort, children were retested on the fourth and seventh day of hospitalization. Abnormal amylase/lipase were found in 49 (51%) children on the fourth and 19 (19.8%) children on the seventh day of hospitalization. We found that SIRS and abnormal amylase/lipase on the seventh day of hospitalization were both independent risk factors of RAP, which reflected a severe inflammatory response and severe pancreatic injury. SIRS and elevated amylase/lipase levels are caused by the release of large amounts of cytokines and trypsin into the blood. The presence of SIRS indicates local inflammation spreading throughout the system, which leaves potential inflammatory factors even after effective treatment and can cause RAP under certain triggers. These factors may offer an objective metric to assess for those children at risk of developing RAP.
The start time of enteral nutrition is of great significance. At present, it is believed that the earlier the enteral nutrition begins, the better the prognosis of the disease. It can prevent ectopic intestinal flora, reduce the risk of complications (mortality, infection and multiple organ failure) and shorten hospital stay.20 21 29 We found that longer fasting time is one of the independent risk factors of pediatric RAP. Moreover, there was a significant correlation between fasting time and hospitalization time (p<0.0001, r2=0.5961). Therefore, enteral nutrition should be started as early as possible provided gastrointestinal function is tolerated in pediatric AP.
There are limitations to our study worth noting. This is a retrospective cohort study, so that there was no initial protocol and led to partial missing clinical data. MRI was not performed in all children, which might have caused some of the cases to be erroneously labeled as idiopathic AP. Moreover, the sample size is small, so that the results may not be generalizable, and some variables cannot be statistically processed. The number of RAP was small, which may limit the statistical processing and bias the results.
In conclusion, most children who developed RAP had progressed within 6 months after their first episode of AP. Patients with AP who met all three AP diagnostic criteria at initial attack and with SIRS, longer fasting time and abnormal amylase/lipase value on the seventh day of hospitalization are associated with higher risk of RAP.